ISORAY INC (ISR) Stock Price, Quote, News and Overview
NYSEARCA:ISR - NYSE Arca - US46489V1044 - Common Stock - Currency: USD
ISR Quote, Performance and Key Statistics
NYSEARCA:ISR (2/17/2023, 8:04:00 PM)
0.384
+0 (+0.03%)
The current stock price of ISR is 0.384 USD. In the past month the price increased by 37.14%. In the past year, price increased by 2.4%.
ISR Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.97 | 357.10B | ||
| AMGN | AMGEN INC | 15.29 | 162.72B | ||
| GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
| NTRA | NATERA INC | N/A | 21.43B | ||
| BIIB | BIOGEN INC | 8.54 | 20.49B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Related stock screener links
About ISR
Company Profile
IsoRay, Inc. is a medical technology company, which engages in the development, manufacture, and sale of isotope-based medical products and devices. The company is headquartered in Richland, Washington and currently employs 66 full-time employees. The company went IPO on 2002-05-31. The firm is engaged in the advancement of treatment applications for cancers throughout the body. The company is a producer of Cesium-131 brachytherapy seeds. The firm has also developed a lead-212 generator to secure isotope supply for clinical trials and commercial operations. Its lead-212 generator utilizes the isotope lead-212 to deliver alpha radiation specifically to cancer cells via specialized targeting peptides. The firm is also engaged in the development of imaging diagnostics. The Company’s melanoma (VMT01) and neuroendocrine tumor (VMT-a-NET) programs are under Phase I/IIa imaging and therapy trials for the treatment of metastatic melanoma and neuroendocrine tumors at various academic institutions.
Company Info
ISORAY INC
350 Hills Street, Suite 106
Richland WASHINGTON 99354 US
CEO: Lori A. Woods
Employees: 66
Company Website: https://isoray.com/
Phone: 15093751202.0
ISORAY INC / ISR FAQ
What is the stock price of ISORAY INC today?
The current stock price of ISR is 0.384 USD. The price increased by 0.03% in the last trading session.
What is the ticker symbol for ISORAY INC stock?
The exchange symbol of ISORAY INC is ISR and it is listed on the NYSE Arca exchange.
On which exchange is ISR stock listed?
ISR stock is listed on the NYSE Arca exchange.
What is the price forecast or stock price prediction for ISORAY INC stock?
6 analysts have analysed ISR and the average price target is 1.02 USD. This implies a price increase of 165.63% is expected in the next year compared to the current price of 0.384. Check the ISORAY INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is ISORAY INC worth?
ISORAY INC (ISR) has a market capitalization of 107.00M USD. This makes ISR a Micro Cap stock.
How many employees does ISORAY INC have?
ISORAY INC (ISR) currently has 66 employees.
What are the support and resistance levels for ISORAY INC (ISR) stock?
ISORAY INC (ISR) has a support level at 0.36 and a resistance level at 0.42. Check the full technical report for a detailed analysis of ISR support and resistance levels.
Is ISORAY INC (ISR) expected to grow?
The Revenue of ISORAY INC (ISR) is expected to grow by 44.05% in the next year. Check the estimates tab for more information on the ISR EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy ISORAY INC (ISR) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of ISR, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of ISR, evaluating the profitability, health, valuation and growth aspects
- ISORAY INC (ISR) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ISORAY INC (ISR) Sales and EPS estimates to see what analysts future expectations are.
- ISORAY INC (ISR) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ISORAY INC (ISR) Insider and Institutional Ownership to learn about the owners and their transactions.
- ISORAY INC (ISR) Stock Chart to make your own analysis
- ISORAY INC (ISR) Latest news and press-releases to stay up to date.
Does ISORAY INC (ISR) stock pay dividends?
ISR does not pay a dividend.
What is the Price/Earnings (PE) ratio of ISORAY INC (ISR)?
ISORAY INC (ISR) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.06).
ISR Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to ISR. When comparing the yearly performance of all stocks, ISR is one of the better performing stocks in the market, outperforming 77.63% of all stocks.
ISR Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to ISR. ISR has a great financial health rating, but its profitability evaluates not so good.
ISR Financial Highlights
Over the last trailing twelve months ISR reported a non-GAAP Earnings per Share(EPS) of -0.06. The EPS decreased by -20% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
ISR Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to ISR. The Buy consensus is the average rating of analysts ratings from 6 analysts.
For the next year, analysts expect an EPS growth of -1% and a revenue growth 44.05% for ISR